MONDAY, March 9, 2026 -- For patients with HIV-1 with virologic suppression on complex multipill regimens, the bictegravir-lenacapavir single-tablet...

MONDAY, March 9, 2026 -- For patients with HIV-1 with virologic suppression on complex multipill regimens, the bictegravir-lenacapavir single-tablet...

Lenacapavir (brand name Sunlenca) is a groundbreaking, FDA-approved, twice-yearly injectable medication used for both HIV prevention (PrEP) and...

Lenacapavir (brand name Sunlenca) is a groundbreaking, FDA-approved, twice-yearly injectable medication used for both HIV prevention (PrEP) and...

Lenacapavir is an injectable treatment administered twice a year, making it a more convenient alternative to daily oral prevention drugs. The National...

Lenacapavir is an injectable treatment administered twice a year, making it a more convenient alternative to daily oral prevention drugs. The National...

People who have lived with HIV long-term can need up to a dozen pills every day to suppress the virus. Results from a new drug trial raise hope of...

People who have lived with HIV long-term can need up to a dozen pills every day to suppress the virus. Results from a new drug trial raise hope of...

SCIENTISTS have discovered a secret gene that makes carriers more resistant to smoking with the hope of one day offering new treatments for those who...

SCIENTISTS have discovered a secret gene that makes carriers more resistant to smoking with the hope of one day offering new treatments for those who...